Staar surgical co (STAA)
Income statement / TTM
Apr'20Jan'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales

152,789

150,185

142,488

135,203

129,444

123,954

117,620

109,323

97,354

90,611

87,896

84,475

83,513

82,432

81,153

79,851

77,534

77,123

72,838

72,276

73,667

74,987

77,358

76,276

74,392

72,215

69,737

68,497

66,275

63,783

63,698

63,098

63,425

62,765

59,536

57,909

0

0

0

Cost of sales

40,255

38,231

36,366

34,272

33,185

32,444

31,722

30,436

28,220

26,331

25,118

23,674

23,560

24,063

23,998

24,769

24,717

24,400

25,376

25,744

25,829

26,164

24,962

23,690

22,853

21,906

21,236

20,879

20,232

19,492

19,146

19,272

19,783

20,396

20,336

20,480

0

0

0

Gross profit

112,534

111,954

106,122

100,931

96,259

91,510

85,898

78,887

69,134

64,280

62,778

60,801

59,953

58,369

57,155

55,082

52,817

52,723

47,462

46,532

47,838

48,823

52,396

52,586

51,539

50,309

48,501

47,618

46,043

44,291

44,552

43,826

43,642

42,369

39,200

37,429

0

0

0

Selling, general and administrative expenses:
General and administrative

30,445

29,313

27,676

26,665

25,353

24,287

22,770

21,399

19,888

19,465

18,042

18,311

18,554

21,671

23,231

23,099

22,907

19,604

19,015

17,421

18,053

18,287

18,773

19,654

18,209

16,771

16,228

15,538

15,248

15,150

14,890

15,123

15,395

14,932

14,576

14,161

0

0

0

Marketing and selling

46,376

45,491

44,155

42,312

41,289

38,600

36,768

32,643

29,326

28,402

27,047

27,701

27,540

28,685

27,916

27,051

25,702

23,695

23,473

24,215

25,409

25,879

27,606

26,107

24,740

23,888

22,217

22,197

21,904

21,281

20,164

19,096

17,930

17,726

17,650

17,345

0

0

0

Research and development

26,561

25,298

23,594

23,008

22,256

22,028

22,223

21,247

20,668

20,044

18,794

18,653

18,545

20,668

19,980

19,211

18,088

14,761

14,043

13,496

12,458

12,363

11,091

9,638

8,826

6,708

6,539

6,437

6,264

6,444

6,230

6,102

5,982

5,868

5,588

5,510

0

0

0

Medical device tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

149

104

59

0

0

0

0

-

-

-

-

-

-

Other general and administrative expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

321

571

1,061

1,509

2,242

2,660

2,898

2,982

2,636

2,577

1,986

1,482

1,060

1,163

0

0

-

0

Total selling, general and administrative expenses

103,382

100,102

95,425

91,985

88,898

84,915

81,761

75,289

69,882

67,911

65,847

66,810

0

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating income (loss)

9,152

11,852

10,697

8,946

7,361

6,595

4,137

3,598

-748

-3,631

-1,105

-3,864

-4,686

-12,655

-13,972

-14,279

-13,880

-5,337

-9,017

-8,548

-8,195

-8,027

-5,536

-3,810

-1,726

700

708

444

-414

-1,220

691

1,519

2,853

2,783

923

-613

0

0

0

Other income (expense), net:
Interest income, net

933

988

1,026

731

448

165

-89

-87

-96

-112

-286

-230

-168

-112

66

66

70

78

150

156

157

154

110

113

120

170

226

253

279

291

310

379

465

523

592

682

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

51

33

35

33

59

97

95

94

59

21

21

19

32

32

38

0

0

0

Loss on foreign currency transactions

-737

-517

-1,112

-476

-1,007

-836

-464

-72

828

819

578

105

-691

-147

-244

-195

401

-949

-892

-1,540

-1,854

-896

-619

235

446

39

64

29

-297

111

-72

-540

-219

86

613

501

0

0

0

Royalty income

474

551

608

661

647

633

646

628

607

581

511

504

727

618

872

962

717

740

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

56

152

145

159

162

82

102

43

59

47

8

-41

-99

-148

-194

-83

-50

19

-248

-240

-109

26

42

121

134

64

571

528

698

822

579

450

377

326

446

435

0

0

0

Loss on early extinguishment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income (expense), net

726

1,174

667

1,075

250

44

195

512

1,398

1,335

983

452

-175

211

318

569

998

-268

-485

-1,349

-1,678

-618

-232

700

915

414

506

399

216

701

218

-448

-288

-79

499

25

0

0

0

Income (loss) before income taxes

9,878

13,026

11,364

10,021

7,611

6,639

4,332

4,110

650

-2,296

-122

-3,412

-4,861

-12,444

-13,654

-13,710

-12,882

-5,605

-9,502

-9,897

-9,873

-8,645

-5,768

-3,110

-811

1,114

1,214

843

-198

-519

909

1,071

2,565

2,704

1,422

-588

0

0

0

Provision (benefit) for income taxes

-2,669

-1,022

2,599

2,185

1,859

1,671

598

662

3

-157

2,046

1,707

1,430

-315

-850

-932

-648

928

-1,273

-714

-500

-253

962

389

621

716

1,354

1,598

1,326

1,244

1,148

1,143

1,285

1,356

1,342

1,037

0

0

0

Income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net income (loss)

12,547

14,048

8,765

7,836

5,752

4,968

3,734

3,448

647

-2,139

-2,168

-5,119

-6,291

-12,129

-12,804

-12,778

-12,234

-6,533

-8,229

-9,183

-9,373

-8,392

-6,730

-3,499

-1,432

398

-140

-755

-1,524

-1,763

-239

-72

1,280

1,348

80

-1,625

0

0

0

Net income (loss) per share:
Net loss per share - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.05

-0.20

-0.03

-0.04

-0.04

-0.06

-

-0.07

-0.05

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,210

39,983

39,766

39,727

39,066

38,481

-

38,369

38,168

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) per share from continuing operations - basic (in dollors per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

-0.05

Income (loss) per share from continuing operations - diluted (in dollors per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.03

-0.05

Basic

0.00

0.15

0.05

0.09

0.03

0.04

0.03

0.04

0.01

-0.01

0.03

-0.02

-0.05

-

-0.04

-

-

-

-

-

-

-

-

-

-0.04

-0.02

0.01

0.01

0.01

-0.05

0.00

-0.01

0.01

0.01

0.00

0.02

0.01

-0.03

-0.05

Diluted

0.00

0.14

0.05

0.08

0.03

0.03

0.03

0.04

0.01

-0.01

0.03

-0.02

-0.05

-

-0.04

-

-

-

-

-

-

-

-

-

-0.04

-0.02

0.01

0.01

0.01

-0.05

0.00

-0.01

0.01

0.01

0.00

0.02

0.01

-0.03

-0.05

Weighted average shares outstanding:
Basic

44,953

44,695

44,563

44,479

44,235

44,161

43,054

41,723

41,410

41,224

41,110

40,933

40,749

-

40,486

-

-

-

-

-

-

-

-

-

37,794

37,151

36,750

36,496

36,427

36,392

36,292

36,257

36,071

35,566

35,539

35,443

35,188

34,831

34,790

Diluted

44,953

47,077

46,857

46,733

46,913

47,917

46,025

43,999

43,087

40,230

42,104

40,933

40,749

-

40,486

-

-

-

-

-

-

-

-

-

37,794

39,384

39,284

38,342

37,418

34,043

36,292

36,257

38,420

37,731

36,953

36,439

36,389

34,831

34,790